January 29th 2021
A 4-biomarker panel can help ensure rheumatoid arthritis (RA) is accurately diagnosed, according to study results published in Arthritis Research & Therapy.
Study Investigates Role of Temperature in RA Activity
January 3rd 2021Previous studies have shown conflicting characteristic thermographic patterns of the feet in patients with active rheumatoid arthritis (RA). This study probed whether the thermal characteristics of the feet of patients in remission differ to those of healthy controls.
Read More
Dementia in Patients With RA Lower in Those Using Biologics, Study Says
January 2nd 2021Previous studies have suggested that inflammatory diseases such as rheumatoid arthritis (RA) can increase the risk for dementia and that tumor necrosis factor agents may have a role in preventing the incidence of dementia.
Read More
Immunosuppressive Drugs for Autoimmune Disease May Reduce Risk of ARDS in COVID-19 Hospitalizations
December 27th 2020Immunosuppressed patients who had an autoimmune disease (AD) were significantly less likely to develop severe acute respiratory distress syndrome (ARDS) compared with patients who were not immunosuppressed and did not have an AD.
Read More
Specialty Drug Spending After State-Mandated Out-of-Pocket Caps
August 6th 2020Despite concerns, legislation to cap out-of-pocket payments for specialty drugs has not been shown to shift costs to health plans, thereby increasing insurance premiums, according to a study published in New England Journal of Medicine.
Read More
Evaluating the Presence and Impact of Comorbidities in Rheumatoid Arthritis
July 22nd 2020Comorbidities are common in patients with rheumatoid arthritis, and the presence of comorbidities reduces the chance of remission and is associated with worse functional status and disease activity measures.
Read More
Predicting Flares of Rheumatoid Arthritis Disease Activity
July 16th 2020Research identified a new type of cell that is in the blood during the period before a rheumatoid arthritis flare and may be used to predict a flare in the weeks before one occurs, according to research published in New England Journal of Medicine.
Read More
Assessing the Frequency and Impact of Autoimmune Diseases With Hematological Disorders
July 11th 2020Two abstracts presented at the European Hematology Association's annual meeting evaluated the frequency of myeloid malignancies in patients with autoimmune disease and the impact autoimmune diseases have on patients with sickle cell disease.
Read More
Patients With SLE Experienced Delayed Access to Hydroxychloroquine During COVID-19 Pandemic
July 8th 2020Patients with systemic lupus erythematosus (SLE) may consider hydroxychloroquine essential to their treatment, but after the drug was identified as a potential therapy for coronavirus disease 2019 (COVID-19), patients with SLE experienced reduced access to the treatment, which could increase the risk of SLE flare.
Read More
Analysis Finds Clinical Insights for Treating AIHA, Non-Hodgkin Lymphoma
February 22nd 2020Though rare, patients with both autoimmune hemolytic anemia (AHIA) and non-Hodgkin lymphoma face stark odds of long-term survival. A new study lends insights into how to best diagnose and treat those patients.
Read More
Inebilizumab Results for NMOSD Presented at ECTRIMS, With Public Offering on Way
September 12th 2019FDA recently accepted the Biologics Licensing Application for inebilizumab to treat a rare autoimmune condition, neuromyelitis optica spectrum disorder. The results for inebilizumab were presented at the 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis, taking place in Stockholm, Sweden.
Read More
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence
July 17th 2019Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Read More